vaccin
anim
prevent
infecti
diseas
practis
number
year
littl
chang
product
composit
recent
advanc
molecular
biolog
pathogenesi
immunolog
laid
groundwork
develop
new
gener
veterinari
vaccin
base
pure
subunit
well
live
vector
bacteria
virus
along
novel
method
antigen
prepar
use
new
adjuv
deliveri
system
permit
target
appropri
immun
respons
well
offer
flexibl
term
vaccin
protocol
new
technolog
also
appli
develop
vaccin
enhanc
anim
product
control
reproduct
vaccin
anim
infecti
diseas
proven
one
costeffect
mean
reduc
anim
suffer
econom
loss
due
bacteri
viral
infect
howev
infecti
diseas
continu
problem
despit
continu
use
convent
product
decad
technolog
vaccin
develop
product
remain
basic
past
year
involv
use
either
kill
organ
combin
adjuv
live
organ
reduc
virul
advanc
immunolog
pathogenesi
past
two
decad
base
larg
recombin
dna
technolog
monoclon
antibodi
molecular
genet
form
basi
new
gener
veterinari
productswhich
start
enter
marketplac
continu
forese
futur
subunit
vaccin
compos
protect
antigen
cost
la
babiuk
potrer
effect
produc
use
gene
express
technolog
number
system
includ
bacteria
fungi
insect
cell
destruct
nondestruct
mammalian
system
parallel
identif
product
subunit
antigen
new
adjuv
deliveri
system
develop
allow
one
stimul
appropri
immun
respons
antibodi
vs
cellmedi
desir
site
sinc
mani
viral
bacteri
pathogen
colon
mucos
surfac
deliveri
antigen
site
crucial
stimul
mucos
immun
system
new
carrier
cholera
toxin
microcarri
use
cytokin
antigen
chimera
offer
abil
deliv
subunit
mucos
surfac
live
vector
arguabl
better
choic
stimul
mucos
immun
rapid
advanc
made
develop
live
bacteri
viral
vaccin
base
ration
attenu
method
live
vaccin
use
number
year
exact
mechan
attenu
often
unclear
genet
lesion
respons
reduct
virul
character
therefor
possibl
revers
virul
remain
remot
possibl
ration
attenu
reli
construct
well
character
delet
specif
gene
code
essenti
physiolog
function
virul
determin
much
work
bacteri
attenu
focuss
salmonella
ophimurium
although
number
organ
similarli
attenu
likewis
attenu
herpesvirus
adenovirus
also
construct
genedelet
organ
use
monoval
vaccin
hold
greater
promis
deliveri
heterolog
antigen
area
vaccinolog
histor
focuss
control
infecti
diseas
consider
interest
recent
modul
anim
product
behaviour
reproduct
immun
hormon
receptor
vaccin
decreas
fertil
develop
use
synthet
peptid
technolog
commerci
avail
product
follow
other
produc
recombin
dna
technolog
present
review
attempt
summar
present
vaccin
well
highlight
recent
discoveri
shape
vaccin
futur
vaccin
anim
prevent
bacteri
infect
practis
number
year
use
kill
live
product
mani
diseas
proven
effect
reduc
clinic
sign
diseas
room
improv
safeti
efficaci
product
mani
vaccin
compos
kill
bacteria
combin
adjuv
increas
immun
respons
type
product
quit
inexpens
produc
sever
inher
problem
includ
antigen
competit
protect
nonprotect
compon
omiss
protect
antigen
due
growth
condit
downstream
process
presenc
potenti
harm
compon
bacteria
larg
number
compon
surfac
bacteria
protect
make
small
fraction
present
immun
system
follow
vaccin
antigen
competit
ultim
result
decreas
respons
protect
antigen
correspond
decreas
efficaci
product
problem
compound
vaccin
contain
multipl
serotyp
organ
one
bacteri
speci
exampl
serotyp
actinobacillu
pleuuropneumonia
streptococcu
sui
includ
vaccin
sever
need
broad
spectrum
protect
known
mani
import
virul
determin
potenti
protect
antigen
produc
cultur
condit
mimic
found
host
exampl
outer
membran
protein
involv
iron
acquisit
gramneg
bacteria
usual
produc
absenc
free
iron
therefor
produc
normal
laboratori
growth
condit
likewis
synthesi
virul
determin
toxin
fimbria
regul
similar
fashion
ironregul
membran
protein
shown
protect
antigen
number
system
therefor
manipul
growth
condit
increas
express
may
improv
efficaci
whole
cell
prepar
bacterin
prepar
often
compos
cellular
materi
therefor
also
lack
protect
immunogen
found
supernat
excel
exampl
type
virul
determin
would
rtx
toxin
produc
bacteria
pasteurella
haemotica
actinobacillu
pleuropneumonia
agent
respons
pneumonia
cattl
pig
respect
case
toxin
shown
protect
immunogen
ancl
therefor
could
consid
essenti
vaccin
compon
new
product
enrich
secret
toxin
shown
efficaci
field
condit
final
bacterin
prepar
may
includ
compon
lipopolysaccharid
interfer
immun
respons
protect
compon
remov
would
increas
vaccin
efficaci
despit
problem
numer
exampl
bacterinbas
vaccin
proven
effect
includ
vibriosi
carapylobacterfetu
calf
scour
escherichia
coli
ovin
footrot
sacteroid
nodosu
clostridi
infect
e
coli
mastiti
name
furthermor
use
similar
vaccin
help
identifi
specif
virul
determin
protect
compon
serv
basi
vaccin
improv
exampl
vaccin
whole
cell
prepar
e
coli
establish
protect
capac
fimbria
subsequ
led
develop
extract
product
enrich
protect
antigen
likewis
recombin
vaccin
ovin
footrot
develop
due
earlier
studi
conduct
whole
cell
prepar
see
next
section
therefor
vaccin
bacterin
proven
percent
effect
use
first
gener
product
case
could
probabl
improv
upon
term
efficaci
bacteri
extract
view
refin
whole
cell
vaccin
specif
protect
compon
enrich
problem
antigen
competit
somewhat
reduc
extract
vaccin
downstream
process
procedur
shown
increas
safeti
efficaci
product
limit
number
live
bacteri
vaccin
develop
use
convent
technolog
includ
vitro
passag
passag
nonhost
anim
chemic
mutagenesi
brucella
abortu
strain
use
extens
live
vaccin
percent
immun
anim
develop
protect
immun
streptomycindepend
mutant
p
haemotica
p
multocma
grow
absenc
antibiot
develop
vaccin
found
widespread
use
genet
lesion
respons
attenu
report
new
live
vaccin
attenu
mechan
exact
structur
mutat
known
develop
offer
attract
altern
vaccin
convent
live
kill
product
see
subunit
vaccin
true
subunit
vaccin
contain
one
protect
antigen
attract
sinc
compon
requir
induct
protect
cell
mediat
andor
humor
immun
respons
present
offer
flexibl
term
vaccin
formul
adjuv
choic
mechan
vaccin
deliveri
numer
virul
determin
produc
veterinari
bacteri
pathogen
identifi
character
past
year
includ
adhesin
capsular
polysaccharid
toxin
outer
membran
protein
other
howev
purif
compon
convent
biochem
techniqu
gener
feasibl
vaccin
product
due
high
downstream
process
cost
recombin
dna
technolog
high
level
gene
express
offer
attract
altern
cost
effect
product
bacteri
subunit
although
vaccin
current
produc
way
anticip
sever
new
product
follow
near
futur
number
bacteri
express
system
avail
result
desir
produc
percent
total
cell
protein
includ
gramneg
bacteria
e
coli
ieudomona
aeruginosa
gramposit
organ
staphylococcu
aureu
bacillu
subtili
high
level
gene
express
e
coli
often
result
recombin
protein
insolubl
form
inclus
bodi
must
harvest
solubilizod
prior
use
proven
effect
bacteri
antigen
eg
p
haemoa
lkta
pleuropneumonia
tfba
cyta
omla
other
may
requir
extens
downstream
process
refold
protein
prior
formul
also
system
result
formul
solubl
product
like
find
use
mainli
antigen
requir
biolog
activ
assembl
induct
protect
immun
respons
fimbria
excel
exampl
antigen
requir
assembl
cell
surfac
effect
ovin
footrot
vaccin
contain
recombin
nodosu
fimbria
produc
use
p
aeruginosa
host
recombin
fimbria
antigen
ident
isol
origin
b
mdosu
strain
fimbrial
gene
clone
e
coli
host
assembl
fimbria
occur
unassembl
subunit
protein
protect
illustr
import
choos
appropri
express
system
host
product
recombin
protein
anoth
fimbrialbas
vaccin
prevent
ofe
coli
scour
pig
also
develop
case
host
gene
express
e
coli
strain
vaccin
contain
equal
quantiti
fimbria
footrot
scour
vaccin
could
produc
natur
host
bacteria
use
convent
purif
techniqu
howev
recombin
bacteria
produc
ten
time
fimbria
easier
grow
high
cultur
densiti
also
one
fimbrial
type
produc
one
strain
make
product
even
cost
effect
gramposit
express
system
particularli
use
secret
recombin
protein
growth
medium
facilit
product
recoveri
sinc
cell
disrupt
requir
one
aureu
system
base
protein
spa
gene
shown
direct
secret
product
growth
medium
e
coil
aureu
recombin
dna
technolog
also
allow
one
modifi
gene
interest
produc
chimer
molecul
well
antigen
modifi
includ
affin
tag
purif
proteas
site
cleavag
lipid
moieti
may
increas
immunogeni
latter
modif
may
find
use
veterinari
vaccin
replac
oilbas
adjuv
introduc
sinc
adjuv
molecul
coval
link
antigen
thu
make
formul
deliveri
effici
cost
effect
live
bacteri
vaccin
one
excit
area
contemporari
bacteri
vaccinolog
emerg
live
bacteri
vaccin
base
ration
attenu
method
live
vaccin
sever
potenti
advantag
kill
product
includ
abil
deliv
number
rout
one
immun
b
presenc
relev
antigen
includ
express
vivo
sinc
organ
multipli
host
c
abil
elicit
cellmedi
humor
immun
desir
site
within
anim
low
cost
e
abil
serv
vehicl
deliveri
heterolog
antigen
live
vaccin
use
exact
natur
lesion
respons
attenu
unknown
therefor
revers
virul
remain
possibl
advanc
molecular
genet
made
possibl
construct
well
defin
mutat
usual
delet
specif
gene
affect
surviv
host
sinc
establish
infect
requir
express
gene
code
virul
determin
well
compon
need
physiolog
function
cell
mutat
either
group
potenti
reduc
virul
repres
exampl
attenu
mutat
class
list
tabl
howev
sinc
nontox
form
molecul
still
protect
live
vaccin
produc
genet
detoxifi
lkta
gene
product
still
protect
work
live
vaccin
develop
focus
salmonella
speci
attenu
mutat
housekeep
gene
vaccin
aroa
mutant
shown
induc
antibodi
delayedtyp
hypersensit
cytotox
tlymphocyt
respons
mice
one
vaccin
trial
oral
immun
sevendayold
calv
aroa
arod
doubl
mutant
typhimuriurn
result
protect
experiment
challeng
seven
week
later
demonstr
potenti
oral
vaccin
larg
anim
other
shown
anim
vaccin
twice
kill
cell
develop
antibodi
respons
organ
protect
challeng
ophirnurium
pur
mutant
also
attenu
vaccin
result
less
persist
infect
aroa
mutant
therefor
degre
attenu
tailor
desir
level
use
differ
mutat
whichev
type
mutat
approach
use
attenu
bacteria
least
two
lesion
probabl
need
incorpor
order
reduc
risk
revers
virul
mediat
vivo
genet
transfer
anoth
organ
alreadi
accomplish
use
sever
combin
allel
ophimurium
name
high
level
express
foreign
gene
requir
recombin
subunit
vaccin
secret
vector
contain
signal
sequenc
direct
foreign
antigen
cell
surfac
gener
use
although
necessari
case
protect
epitop
protein
identifi
oligonucleotid
code
sequenc
insert
gene
code
surfac
structur
fimbria
flagella
cell
surfac
express
use
promot
activ
host
foreign
antigen
toxic
host
synthes
vaccin
growth
vaccin
strain
principl
host
use
deliv
recombin
antigen
ultim
choic
must
base
safeti
type
immun
desir
recent
interest
develop
mycobacterium
bori
bcg
deliveri
vehicl
heterolog
antigen
bovi
use
extens
vaccin
capabl
induc
strong
humor
cellmedi
immun
respons
capabl
foreign
antigen
present
cell
surfac
howev
system
like
use
mainli
human
vaccin
unless
diagnost
test
distinguish
vaccin
infect
anim
accompani
product
immun
control
viral
diseas
histori
year
develop
livepox
viru
vaccin
follow
subsequ
kill
rabi
viru
vaccin
sinc
initi
observ
variou
approach
control
viral
diseas
immun
develop
includ
virul
virus
ii
simultan
administr
virul
virus
plu
antibodi
iii
modifi
live
attenu
viru
vaccin
iv
kill
vaccin
v
recent
genet
engin
delet
mutant
subunit
vaccin
best
exampl
use
virul
viru
vaccin
infect
laryngotrach
viru
introduc
foreign
site
case
respiratori
viru
administ
cloaca
bird
viru
replic
site
inject
induc
system
mucos
immun
spread
respiratori
tract
unfortun
social
behaviour
manag
practic
poultri
hous
result
transfer
viru
cloaca
respiratori
tract
bird
thu
although
practis
past
without
short
come
therefor
replac
attenu
live
vaccin
administ
eycdrop
method
spray
drink
water
similarli
viru
often
use
immun
lamb
administ
live
virul
viru
scarif
flank
unwool
area
sinc
lamb
attempt
scratch
nuzzl
vaccin
site
transfer
viru
lip
oral
caviti
lamb
concomit
decreas
feed
loss
product
depend
pathogenesi
specif
viru
also
possl
administ
vaccin
time
least
detriment
host
exampl
adult
sow
gener
exhibit
signific
clinic
sign
follow
infect
transmiss
gastrcenter
viru
young
piglet
base
observ
produc
expos
pregnant
sow
virul
viru
prior
parturit
boost
matern
antibodi
level
transfer
piglet
protect
suscept
period
life
similar
approach
use
poultri
lay
hen
immun
virul
infecti
bursal
diseas
viru
viru
littl
impact
adult
bird
induc
product
antibodi
transfer
yolk
subsequ
chick
protect
critic
first
week
life
altern
approach
use
virul
virus
capit
antigen
related
virus
heterotyp
immun
introduc
immun
pig
virul
strain
bovin
viru
diarrhea
bvd
protect
pig
hog
cholera
viru
unfortun
practic
accept
pig
come
contact
cattl
although
virul
virus
use
control
infect
anim
vaccin
use
convent
produc
attenu
live
kill
wholeviru
vaccin
attenu
vaccin
produc
passag
tissu
cultur
unnatur
host
result
multipl
passag
case
mutant
select
reduc
virul
natur
host
mutant
also
develop
chemic
mutagenesi
select
variou
criteria
includ
inabl
replic
bodi
temperatur
temperaturesensit
mutant
although
modifi
live
virus
replic
b
vivo
induc
subclin
infect
concomit
immun
sinc
modifi
live
vaccin
replic
safeti
recent
challeng
attenu
mutat
produc
random
therefor
imposs
predict
mutat
occur
furthermor
circumst
may
revert
virul
mutat
singl
point
mutat
revert
back
virul
upon
singl
passag
vivo
secondli
attenu
vaccin
shown
immunosuppress
characterist
major
concern
situat
anim
may
immun
multipl
vaccin
common
practic
consequ
immunosuppress
may
poor
immun
respons
concurr
administ
vaccin
increas
suscept
concurr
infect
fact
livevir
vaccin
need
refriger
prior
administr
ensur
viabil
combin
concern
increas
use
kill
vaccin
especi
case
rural
less
develop
region
world
unfortun
induc
adequ
longlast
immun
kill
viral
vaccin
requir
high
dose
antigen
strong
adjuv
repeat
administr
maintain
protect
level
immun
furthermor
method
inactiv
may
alter
crucial
epitop
viru
requir
induc
protect
immun
conventionalkil
vaccin
administ
feed
water
thu
make
administr
vaccin
poultri
extrem
difficult
furthermor
kill
vaccin
gener
induc
mucos
immun
primari
site
entri
virus
sinc
conventional
attenu
kill
vaccin
disadvantag
mani
individu
compani
attempt
circumv
short
come
use
recombin
dna
technolog
develop
better
efficaci
live
subunit
vaccin
poultri
livestock
advanc
molecular
biolog
immunolog
combin
understand
pathogenesi
mani
virus
provid
us
tool
develop
efficaci
safer
vaccin
use
control
viral
infect
anim
although
still
controversi
regard
use
genet
engin
produc
vaccin
regulatori
agenc
compani
recogn
merit
approach
support
recombin
dna
approach
come
mainli
observ
genet
engin
produc
safe
effect
commerci
vaccin
order
maintain
momentum
continu
interact
number
disciplin
biolog
well
consider
econom
vaccin
product
need
consid
virus
possess
varieti
differ
protein
import
induc
protect
humor
cellular
immun
other
relev
protect
may
inde
detriment
virtu
abil
induc
immunosuppress
enhanc
viral
infect
thu
subunit
vaccin
crucial
identifi
one
two
protein
epitop
involv
induc
protect
immun
identifi
next
step
isol
express
gene
code
protein
appropri
express
system
although
one
could
chemic
synthes
individu
epitop
econom
express
number
epitop
tandem
express
system
inde
possibl
express
seri
epitop
one
express
cassett
produc
string
bead
vaccin
protect
seri
viral
diseas
number
express
system
use
produc
larg
quantiti
viral
protein
subunit
vaccin
includ
prokaryot
system
eukaryoti
system
includ
yeast
mammalian
cell
insect
cell
prokaryot
system
attract
vaccin
product
sinc
yield
often
extrem
high
cost
ferment
downstream
process
low
case
possibl
produc
much
total
cell
protein
specif
desir
product
unfortun
mani
viral
glycoprotein
prokaryot
system
suitabl
sinc
posttransl
modifi
protein
appropri
furthermor
mani
conform
epitop
reconstruct
cultur
addit
reduc
cost
remov
serum
cultur
reduc
potenti
problem
extran
agent
present
vaccin
biggest
disadvantag
insect
cell
cultur
system
progress
insect
cultur
ferment
still
infanc
thu
unlik
yeast
prokaryot
system
larg
scale
ferment
liter
yet
achiev
routin
sinc
physiolog
state
insect
cultur
system
appear
influenc
final
yield
protein
signific
progress
cultur
insect
cell
requir
use
routin
commerci
product
ultim
eukaryot
express
system
produc
authent
viral
glycoprotein
mammalian
cell
advantag
mammalian
cell
system
clone
eukaryot
gene
often
express
fulli
function
process
protein
two
differ
approach
use
produc
protein
mammalian
cell
includ
lytic
system
use
mammalian
virus
engin
express
foreign
gene
nonlyt
cell
system
vaccinia
viru
one
first
mammalian
virus
use
express
foreign
antigen
similar
approach
adapt
use
poxvirus
virus
includ
herp
adenovirus
also
proven
extrem
use
express
foreign
protein
mammalian
cell
unfortun
use
virus
vehicl
product
protein
two
major
disadvantag
first
viru
must
remov
purif
process
ensur
liveviru
present
vaccin
second
sinc
infect
process
result
destruct
cultur
batch
vaccin
requir
scaleup
cell
master
seed
way
final
ferment
expens
time
consum
overcom
impedi
novel
mammalian
express
system
develop
wherebi
gene
introduc
mammalian
cell
secret
protein
continu
unfortun
case
yield
protein
rel
low
overcom
impedi
recent
develop
mammalian
cell
express
system
produc
larg
quantiti
secret
protein
control
heat
shock
promot
cell
cultur
microcarri
convent
mammalian
cell
ferment
expos
elev
temperatur
activ
promot
drive
product
protein
extend
period
time
cell
recycl
numer
heat
shock
secret
cycl
produc
larg
quantiti
protein
extend
period
time
system
provid
opportun
produc
protein
toxic
host
cell
secret
protein
growth
cell
serum
free
media
provid
econom
downstream
process
step
although
system
use
produc
singl
protein
easili
adapt
produc
chimer
protein
similar
report
paramyxovirus
parainfluenza
f
iin
respiratori
syncyti
viru
f
g
protein
even
combin
protein
differ
virus
f
rsv
hn
parainfluenza
sinc
product
secret
protein
result
slightli
modifi
protein
imper
test
protein
abil
induc
cell
mediat
humor
immun
respons
gene
delet
viral
vaccin
previous
describ
random
mutat
occur
attenu
livevir
vaccin
mutat
local
mutat
point
mutat
probabl
occurr
back
mutat
high
make
vaccin
rel
riski
understand
role
differ
gene
virul
possibl
identifi
locat
specif
gene
delet
entir
viru
inde
first
licens
veterinari
vaccin
use
genet
engin
liveattenu
viru
pseudorabi
produc
delet
thymidin
kinas
gene
base
origin
success
larg
number
gene
code
nucleic
acid
metabol
thymidin
kinas
dutpas
structur
nonstructur
protein
delet
test
attenu
case
possibl
identifi
nonessenti
gene
could
delet
viru
alter
virul
approach
dramat
reduc
possibl
revers
virul
sinc
difficult
reacquir
delet
gene
addit
attenu
viru
introduc
delet
approach
also
provid
opportun
develop
companion
diagnost
test
differenti
carrier
anim
vaccin
extrem
valuabl
countri
erad
specif
diseas
desir
approach
extrem
attract
erad
herpesvirus
induc
latent
infect
present
companion
diagnost
test
avail
differenti
pseudorabi
viru
vaccin
carrier
anim
similar
approach
develop
bovin
herpesvirus
addit
abl
genet
attenu
virus
introduc
appropri
delet
possibl
introduc
foreign
gene
delet
region
genom
thu
attenu
viral
strain
would
function
vaccin
could
act
deliveri
vehicl
introduc
antigen
organ
vaccinia
viru
one
first
virus
foreign
viral
gene
insert
continu
extrem
attract
vector
vaccin
deliveri
sinc
genom
larg
possibl
delet
larg
quantiti
genom
still
maintain
viabl
viru
anoth
attract
featur
vaccinia
viru
econom
cultur
cell
also
thermal
stabl
number
countri
use
vaccinia
viru
vector
infecti
diseas
wildlif
speci
exampl
vaccinia
viru
contain
rabi
viru
glycoprotein
gene
becom
wide
use
control
wildlif
rabi
thermal
stabil
viru
allow
incorpor
bait
seed
rural
area
fox
raccoon
skunk
potenti
carrier
rabi
viru
eat
bait
immun
rabi
viru
use
approach
number
anim
immun
greatli
increas
therebi
reduc
epidemiolog
spread
viru
environ
domest
livestock
human
introduct
gene
rinderpest
vaccinia
viru
attract
approach
control
rinderpest
develop
countri
reduc
environment
concern
distribut
vaccinia
viru
potenti
spread
mammalian
speci
poxvirus
subgroup
avian
activ
pursu
vaccin
vector
attenu
achiev
introduct
cytokin
gene
vaccinia
viru
although
vaccinia
viru
appear
extrem
attract
foreign
gene
insert
virus
herpesvirus
adenovirus
also
activ
investig
vector
vaccin
deliveri
region
identifi
within
genom
numer
anim
herpesvirus
recent
bovin
adenovirus
nonessenti
vitro
vivo
replic
use
vector
possibl
express
foreign
protein
induc
immun
protein
natur
host
exampl
recombin
adenorabi
viru
induc
neutral
antibodi
protect
rabi
viru
challeng
varieti
speci
recent
identif
delet
region
within
bovin
adenoviru
suggest
could
also
attract
vector
bovin
vaccin
dna
immun
one
interest
excit
area
vaccinolog
recent
demonstr
direct
inject
gene
encod
protect
antigen
result
express
protein
develop
immun
protein
although
technolog
describ
recent
progress
extrem
swift
numer
gene
shown
function
variou
tissu
wide
varieti
differ
speci
recent
observ
dna
introduc
egg
b
ovo
immun
induc
antibodi
signific
implic
immun
poultri
paul
johnson
person
commun
recent
product
paramet
livestock
control
diet
probiot
hormon
administr
continu
use
alter
product
anim
evidenc
recent
licens
bovin
somatotrophin
enhanc
milk
product
dairi
cattl
howev
recent
advanc
molecular
biolog
immunolog
endocrinolog
ad
altern
approach
modifi
anim
product
altern
approach
involv
immunologlcauy
alter
hormon
level
vaccin
although
approach
infanc
preliminari
evid
indic
possibl
regul
anim
product
behaviour
immunolog
includ
aggress
feed
convers
growth
rate
carcass
qualiti
reproduct
effici
either
increas
decreas
fertil
behaviour
characterist
anim
basi
new
vaccin
mani
characterist
describ
regul
complex
seri
interact
hormon
hostcel
receptor
interact
hormon
appropri
hostcel
receptor
result
signal
transduct
subsequ
alter
cellular
function
includ
product
hormon
regulatori
molecul
thu
antibodi
could
produc
specif
hormon
hostcel
hormon
receptor
block
interact
hormon
host
cell
regul
cellular
function
alter
theori
appear
straight
forward
one
consid
hormon
endogen
protein
requir
gener
autoimmun
respons
problem
induc
immun
endogen
hormon
complic
fact
mani
hormon
small
exampl
gunadotrophin
releas
hormon
gnrh
amino
acid
size
overcom
problem
size
low
immunogen
peptid
steroid
hormon
conjug
carrier
molecul
combin
strong
adjuv
although
proven
effect
alter
molecul
often
occur
conjug
carrier
molecul
consequ
induc
inappropri
immun
respons
overcom
limit
fusion
protein
produc
contain
carrier
hormon
singl
chimer
protein
approach
often
result
immun
respons
epitop
involv
interact
hostcel
receptor
furthermor
possibl
express
number
repeat
hormon
peptid
one
molecul
enhanc
size
immunogen
hormon
approach
use
enhanc
immun
respons
individu
epitop
well
whole
hormon
final
multipl
copi
hormon
epitop
express
conjunct
immun
modul
cytokin
enhanc
immun
respons
hormon
exampl
cytokin
protein
chimer
molecul
becom
numer
case
result
indic
conjug
cytokin
protein
enhanc
immun
respons
coadministr
cytokin
protein
fact
immun
respons
fine
tune
either
develop
thl
respons
allow
appropri
select
cytokin
ensur
antibodi
respons
gener
thu
econom
produc
hormonebas
vaccin
well
improv
efficaci
stimul
neutral
antibodi
respons
appear
within
reach
present
hormon
base
vaccin
primarili
investig
alter
reproduct
growth
manipul
reproduct
major
interest
veterinari
human
medicin
past
year
activ
direct
inhibit
reproduct
function
improv
fecund
effort
result
releas
number
commerci
vaccin
use
livestock
experiment
vaccin
control
reproduct
human
increas
ovul
follow
immun
anim
androstenedion
link
carrier
result
develop
commerci
vaccin
fecundin
similarli
reproduct
enhanc
vaccin
base
hormon
inhibin
promot
releas
follicl
stimul
hormon
fsh
subsequ
increas
ovul
also
develop
addit
activ
immun
enhanc
reproduct
perform
obtain
passiv
immun
anim
demonstr
cattl
inject
monoclon
antibodi
specif
pregnant
mare
serum
gonadotrophin
follow
passiv
immun
increas
ovul
observ
observ
provid
evid
reproduct
perform
increas
passiv
well
activ
immun
although
enhanc
fertil
certain
benefit
interf
reproduct
perform
may
even
benefit
mani
produc
present
surgic
castrat
spay
use
prevent
uncontrol
breed
modifi
undesir
behaviour
pattern
mani
domest
anim
pet
sinc
surgic
castrat
irrevers
search
revers
method
control
reproduct
continu
especi
use
race
hors
pet
case
race
hors
stallion
filli
either
behaviour
problem
perform
full
potenti
sinc
race
potenti
anim
may
known
earli
age
earli
castrat
limit
anim
market
valu
access
desir
blood
line
success
race
career
therefor
revers
immunocastr
would
desir
cattl
earli
breed
result
major
calv
manag
problem
one
could
delay
onset
estru
prevent
ovul
could
signific
impact
anim
product
vaxstrat
gnrh
vaccin
licens
exactli
purpos
recent
probabl
controversi
develop
product
modifi
approach
livestock
precipit
recombin
bovin
growth
hormon
somatotrophin
although
clearli
shown
detriment
effect
administ
somatotrophin
public
opposit
employ
meat
dairi
anim
fierc
therefor
altern
strategi
pursu
endogen
alter
somatotrophin
thu
overcom
percept
hormon
adulter
milk
meat
basi
alter
strategi
primarili
base
observ
enhanc
activ
growth
hormon
achiev
bind
antibodi
somatotrophin
result
enhanc
activ
hormon
actual
mechan
fulli
known
possibl
antigen
antibodi
complex
may
increas
serum
halflif
growth
hormon
altern
interact
antibodi
specif
epitop
growth
hormon
may
increas
hormon
signal
transduct
capac
make
activ
also
possibl
increas
level
growth
hormon
neutral
anoth
hormon
somatostatin
sinc
somatostatin
regul
level
somatrotrophin
releas
decreas
somatostatin
activ
neutral
result
increas
releas
somatotrophin
pituitari
gland
vaccin
contain
somatostatin
enhanc
somatrotrophin
level
plu
epitop
somatotrophin
would
induc
antibodi
enhanc
biolog
activ
somatotrophin
signific
impact
growth
lactat
importantli
alter
carcass
qualiti
influenc
fat
synthesi
howev
approach
embrac
import
determin
effect
somatostatin
immun
may
kill
vaccin
especi
newli
develop
subunit
vaccin
frequent
weak
antigen
stimul
shortliv
igm
antibodi
respons
therefor
order
reduc
amount
antigen
increas
kinet
magnitud
durat
immun
respons
either
adjuv
carrier
requir
method
antigen
deliveri
also
dramat
influenc
qualiti
immun
respons
exampl
due
common
mucos
immun
system
distinct
system
immun
system
immun
mucos
surfac
requir
deliveri
antigen
site
best
achiev
live
vector
describ
howev
mucos
immun
also
achiev
link
antigen
cholera
toxin
carrier
link
antigen
cytokin
incorpor
microcarri
although
adjuv
form
crucial
compon
kill
subunit
vaccin
field
adjuv
deliveri
system
fulli
review
sinc
recent
review
address
area
howev
salient
futur
adjuv
deliveri
subunit
vaccin
describ
word
adjuv
use
mani
way
biolog
medicin
commonli
use
refer
compound
act
nonspecif
manner
augment
specif
immun
antigen
adjuv
capabl
stimul
earlier
stronger
prolong
respons
antigen
use
quantiti
antigen
limit
also
shown
system
immun
respons
antigen
respect
humor
cellular
immun
antibodi
class
subclass
select
manipul
dose
antigen
specif
adjuv
use
vaccin
formul
sever
properti
adjuv
ideal
possess
effect
safe
practic
use
includ
toxic
stabl
easi
use
effect
readili
avail
cheap
lend
qualiti
control
although
numer
compound
present
util
adjuv
fit
desir
criteria
clinic
use
furthermor
adjuv
licens
unless
fundament
understand
mechan
adjuv
function
known
exist
dogma
maintain
deposit
antigen
prolong
period
time
inject
site
promot
immun
respons
deposit
depend
larg
use
nonmetaboliz
miner
oil
antigen
absorb
chemic
compound
alum
propos
deposit
antigen
may
act
two
way
firstli
result
inflammatori
respons
follow
inject
recruit
immun
cell
abl
respond
antigen
secondli
depot
allow
slow
releas
antigen
prolong
period
time
depot
primarili
produc
nonmetaboliz
miner
oil
antigen
adsorb
chemic
compound
alum
miner
oil
alum
adjuv
licens
even
though
induc
granuloma
reduc
granuloma
miner
oil
replac
veget
oil
altern
produc
oil
water
emuls
rather
water
oil
emuls
use
approach
possibl
reduc
concentr
oil
vaccin
second
import
properti
adjuv
activ
macrophag
antigen
present
cell
result
releas
cytokin
immun
modul
exampl
adjuv
stimul
releas
cytokin
includ
bacteri
product
plant
product
lipophil
chemic
dda
avridin
cytokin
help
expand
immun
respons
cell
increas
number
reactiv
cell
third
properti
adjuv
carrier
bind
antigen
host
cell
via
specif
receptor
best
exampl
approach
antigen
link
immunoglobulin
molecul
directli
engin
immunoglobulin
leav
fc
avail
interact
fc
receptor
antigen
present
cell
final
adjuv
act
attract
cell
site
antigen
ensur
appropri
constel
cell
present
vicin
antigen
provid
appropri
stimul
requir
drive
immun
respons
paramet
achiev
combin
adjuv
appropri
deliveri
system
furthermor
type
immun
respons
requir
known
also
possibl
drive
thl
respons
develop
primarili
antibodi
cellmedi
immun
respons
tremend
explos
knowledg
immun
regul
interact
role
cytokin
immun
respons
attract
consider
amount
attent
use
cytokin
immunolog
adjuv
cytokin
either
link
directli
antigen
incorpor
antigen
deliveri
system
sinc
cytokin
regul
cellular
traffic
antigen
present
matur
differenti
lymphocyt
respons
postul
provid
approach
enhanc
direct
immun
respons
thu
cytokin
provid
us
effect
method
enhanc
immun
vaccin
whether
whole
protein
epitop
hormon
regardless
qualiti
antigen
adjuv
subunit
vaccin
improv
appropri
deliveri
especi
import
one
consid
mucos
immun
two
method
deliveri
attract
attent
induc
mucos
immun
includ
biodegrad
microspher
livevector
viral
bacteri
system
see
case
biodegrad
microspher
number
polym
use
adsorb
antigen
surfac
incorpor
antigen
within
polym
microspher
instanc
incorpor
antigen
microspher
protect
antigen
degrad
allow
slow
pulsatil
releas
mani
polym
also
act
adjuv
due
particul
natur
factor
combin
often
lead
significantli
increas
immun
respons
observ
convent
deliveri
system
furthermor
possibl
incorpor
cytokin
immun
modul
microspher
enhanc
immun
respons
base
polym
ratio
differ
compon
antigen
releas
differ
time
extend
period
continu
antigen
stimul
lead
induct
memori
enhanc
immun
respons
sinc
microspher
develop
releas
antigen
differ
time
singl
inject
result
antigen
releas
time
immun
later
time
approach
would
remov
need
booster
immun
especi
import
mani
anim
diseas
manag
system
preclud
multipl
immun
furthermor
singl
immun
would
econom
produc
sinc
would
need
handl
anim
frequent
although
natur
substanc
starch
gelatin
albumin
use
microcarri
develop
popular
compound
use
today
synthet
biodegrad
product
poli
lactid
coglycolid
polym
use
extens
surgeri
resorb
sutur
surgic
clip
control
releas
drug
implant
extens
use
year
provid
confid
regard
safeti
follow
inject
produc
minim
inflammatori
respons
help
initi
immun
respons
degrad
hydrolysi
ester
linkag
produc
lactic
glycol
acid
natur
bodi
constitu
sinc
ratio
lactid
glycolid
copolym
influenc
rate
hydrolysi
possibl
vari
time
antigen
releas
postadministr
variabl
releas
also
achiev
employ
differ
size
microspherc
microsphcrc
less
usual
releas
rapidli
microspher
greater
tlm
size
thu
mixtur
two
differ
prepar
one
releas
antigen
earli
anoth
one
releas
antigen
late
provid
one
singl
vaccin
act
booster
although
differ
size
microspher
produc
report
clearli
indic
regardless
rout
immun
microspher
less
tlm
much
effect
larger
microspber
enhanc
immun
respons
associ
smaller
microsphcr
correl
phagocytosi
transport
particl
region
lymph
node
adjac
inject
site
well
rapid
releas
antigen
second
major
advantag
microspher
potenti
oral
deliveri
vehicl
numer
studi
clearli
shown
microspher
protect
antigen
administ
oral
microspher
less
tlm
size
absorb
cell
taken
macrophag
peyer
patch
antigen
transport
mcsenter
lymph
node
spleen
result
oral
deliveri
mucos
immun
respons
develop
subunit
antigen
approach
provid
altern
livevector
induct
mucosai
immun
mani
pathogen
whether
incorpor
antigen
feed
feasibl
method
reduc
immun
cost
need
explor
possibl
would
dramat
reduc
cost
handl
anim
immun
liposom
also
excel
deliveri
system
enhanc
immun
respons
subunit
antigen
sinc
liposom
made
contain
multipl
antigen
immunomodul
agent
target
liposom
specif
cell
attract
consider
attent
veterinari
vaccin
vaccin
deliveri
system
microcarri
composit
liposom
vari
influenc
antigen
releas
uptak
antigen
present
cell
major
advantag
liposom
iscom
see
natur
antigen
present
simul
deliveri
system
ideal
antigen
immunogen
incorpor
membran
other
need
complex
process
occur
associ
membran
furthermor
antigen
exquisit
sensit
reagent
requir
make
microspher
solvent
heat
etc
liposom
may
provid
altern
antigen
deliveri
microspher
liposom
vari
size
rang
small
unilamillar
multilamillar
vesicl
contain
sever
lipid
bilay
separ
aqueou
layer
furthermor
depend
method
prepar
ratio
phospholipid
cholesterol
specif
amphiphil
immun
stimulatori
complex
iscom
also
shown
potent
antigen
deliveri
system
especi
deliv
glycoprotein
envelop
virus
use
system
greatli
enhanc
immun
respons
demonstr
numer
virus
present
two
vaccin
equin
influenza
felin
leukemia
viru
market
contain
individu
compon
virus
incorpor
iscom
advantag
iscom
induc
signific
humor
immun
also
delay
type
hypersensit
cytotox
cell
immun
respons
follow
parenter
immun
antigen
incorpor
iscom
furthermor
demonstr
effect
deliveri
system
induc
immun
follow
oral
vagin
administr
sinc
wide
rang
immun
respons
elicit
protein
incorpor
iscom
one
must
assum
class
class
ii
respons
induc
indic
antigen
process
follow
deliveri
iscom
occur
endocytot
cytoplasm
pathway
crucial
develop
desir
immun
respons
antigen
iscom
contain
one
viral
envelop
protein
differ
membran
virus
eight
differ
famili
prepar
test
vivo
shown
highli
immunogen
variou
anim
speci
iscom
open
cagelik
structur
normal
nm
diamet
sinc
compos
cholesterol
quill
complex
mixtur
glycosid
isol
bark
quillaja
saponaria
immunogen
therefor
repeatedli
administ
individu
without
advers
side
affect
furthermor
induc
carrierinduc
suppress
major
limit
iscom
solubl
protein
usual
possess
expos
hydrophob
region
therefor
associ
well
iscom
structur
becom
major
impedi
use
sinc
number
express
system
develop
secret
larg
quantiti
protein
media
order
effici
secret
occur
protein
engin
way
remov
hydrophob
membran
anchor
although
provid
mechan
produc
larg
quantiti
recombin
protein
preclud
incorpor
iscom
overcom
difficulti
attempt
made
expos
hydrophob
region
within
protein
partial
denatur
low
ph
treatment
alter
immunogen
protein
approach
use
recent
reed
overcam
impedi
coval
attach
palmit
acid
facilit
incorpor
solubl
protein
iscom
thu
possibl
genet
engin
protein
way
produc
larg
quantiti
solubl
protein
purifi
coval
attach
palmit
acid
incorpor
iscom
altern
approach
would
incorpor
short
hydrophob
tail
genet
engin
method
would
suffici
length
allow
associ
iscom
interfer
secret
protein
media
synthesi
experi
present
progress
reduc
downstream
process
requir
enhanc
immun
respons
subunit
vaccin
recent
progress
infecti
diseas
research
allow
identif
relev
cell
b
cell
epitop
involv
induc
protect
immun
varieti
differ
pathogen
howev
due
small
natur
epitop
immun
respons
often
poor
unless
attach
larger
carrier
protein
overcom
defici
number
individu
genet
engin
epitop
selfassembl
viruslik
particl
includ
incorpor
epitop
hepat
b
tobacco
mosaic
viru
polio
viru
etc
without
disrupt
particl
abil
assembl
furthermor
ensur
epitop
surfaceexpos
although
approach
shown
induc
antibodi
respons
epitop
virus
bacteria
parasit
limit
size
number
epitop
incorpor
selfassembl
panicl
without
disrupt
abil
assembl
overcom
problem
capit
abil
rotaviru
nucleocapsid
protein
selfassembl
viru
particl
also
act
platform
attach
epitop
protein
vari
size
conjug
peptid
nonexpos
mice
thu
use
carrieradjuv
without
worri
carrierinduc
suppress
preliminari
evid
indic
uptak
macrophag
extrem
rapid
macrophag
cultur
subsequ
activ
activ
probabl
result
effici
process
present
antigen
due
increas
product
interleukin
influenc
lymphocyt
subpopul
respond
attach
antigen
addit
attach
epitop
via
differ
linkag
technolog
also
possibl
incorpor
cytokin
therebi
enhanc
immun
respons
exampl
combin
carrier
immun
modulatori
cytokin
enhanc
immun
respons
subunit
antigen
recent
progress
molecular
biolog
protein
engin
immunolog
tremend
impact
abil
identifi
protect
compon
mani
pathogen
includ
epitop
stimul
b
cell
respons
unfortun
econom
product
subunit
protein
suffici
guarante
vaccin
effect
mani
case
vaccin
commerci
incorpor
deliveri
vehicl
adjuv
give
rapid
long
last
immun
prefer
singl
inject
although
adjuv
use
decad
lack
uttderstand
work
adjuv
stimul
appropri
immun
respons
remain
enigma
one
common
theme
appear
emerg
compound
act
adjuv
must
activ
least
cell
immun
system
recent
discoveri
thl
cell
possibl
shift
immun
respons
either
humor
cellular
one
provid
us
consider
appreci
integr
balanc
differ
cytokin
involv
gener
specif
type
immun
respons
therefor
abl
design
effect
vaccin
deliveri
system
consider
knowledg
regard
pathogenesi
host
respons
humor
versu
cellular
involv
clear
specif
pathogen
question
need
knowledg
combin
appreci
differ
adjuv
stimul
product
differ
cytokin
alter
lymphocyt
traffick
induc
antigen
process
trap
import
area
investig
need
pursu
hope
capitalis
recent
advanc
molecular
biolog
product
subunit
vaccin
understand
virul
factor
abil
identifi
gene
code
virul
factor
provid
us
much
ration
approach
attenu
virus
bacteria
delet
specif
gene
therebi
decreas
risk
back
mutat
revert
virul
ensur
safer
vaccin
deliv
oral
mucos
rout
stimul
immun
mucos
site
therebi
block
establish
infect
even
excit
possibl
use
genet
engin
vector
carri
multipl
antigen
pathogen
therebi
provid
opportun
immun
anim
varieti
pathogen
singl
immun
approach
mani
advantag
multipl
vaccin
combin
multipl
pathogen
one
administr
one
major
impedi
rapid
accept
advanc
concern
regulatori
agenc
often
extrem
conserv
confront
new
technolog
hope
consider
success
achiev
vacciniarabi
glycoprotein
recombin
allevi
fear
although
still
number
area
requir
consider
investig
progress
date
provid
level
confid
vaccin
futur
efficaci
safer
past
product
furthermor
advanc
made
past
decad
provid
us
varieti
opportun
alter
vaccin
architectur
requir
provid
protect
varieti
speci
manag
situat
burger
h
g
gener
cytotox
tlymphocyt
respons
use
salmonella
antigendeliveri
system
